Literature DB >> 33732425

Perforating duodenal ulcer with umbilical herniation as a metastatic complication of primary signet ring cell carcinoma of the breast.

Daniel R Principe1, Andreea Raicu2, Jose Cataneo3, Holly R Beverley4, Matthew Hyser5.   

Abstract

Primary signet ring cell carcinoma (SRCC) of the breast is extremely rare, and the associated patterns of metastatic dissemination poorly described. Here, we report the case of a 61-year-old woman presenting with acute abdominal pain. Esophagogastroduodenoscopy revealed a non-bleeding erosive gastropathy, which was biopsied and found significant for a poorly differentiated, GATA3-positive SRCC. The patient was lost to follow up until re-presenting 6 months later with a perforating duodenal ulcer and umbilical herniation. Biopsies of umbilical hernia sack contents were significant for an estrogen receptor (ER) positive SRCC, and breast examination identified a right breast mass significant for an ER positive lobular carcinoma with signet ring features, thereby affirming the diagnosis of metastatic SRCC of the breast. This case offers insight into an advanced form of a rare clinical entity, and suggests that staining for breast markers such as GATA3 should be considered for all biopsies significant for SRCC. Published by Oxford University Press and JSCR Publishing Ltd.
© The Author(s) 2021.

Entities:  

Year:  2021        PMID: 33732425      PMCID: PMC7947957          DOI: 10.1093/jscr/rjab034

Source DB:  PubMed          Journal:  J Surg Case Rep        ISSN: 2042-8812


  9 in total

1.  Breast cancer metastasis to the GI tract may mimic primary gastric cancer.

Authors:  Arifa Abid; Casey Moffa; Dulabh K Monga
Journal:  J Clin Oncol       Date:  2013-01-14       Impact factor: 44.544

2.  Metastatic lobular breast carcinoma mimicking primary signet ring adenocarcinoma in a patient with a suspected CDH1 mutation.

Authors:  Nadim Mahmud; James M Ford; Teri A Longacre; Richard Parent; Jeffrey A Norton
Journal:  J Clin Oncol       Date:  2014-03-03       Impact factor: 44.544

3.  Cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-01-08       Impact factor: 508.702

4.  Ovarian Metastases of Breast Cancers With Signet Ring Cells: A Report of 17 Cases Including 14 Krukenberg Tumors.

Authors:  Jennifer A Bennett; Robert H Young; Ai-Ying Chuang; Melinda F Lerwill
Journal:  Int J Gynecol Pathol       Date:  2018-11       Impact factor: 2.762

5.  Signet-ring cell carcinoma of the breast: a clinicopathologic study of 24 cases.

Authors:  M T Hull; I S Seo; J S Battersby; J F Csicsko
Journal:  Am J Clin Pathol       Date:  1980-01       Impact factor: 2.493

6.  GATA-3 immunohistochemistry in the differential diagnosis of adenocarcinoma of the urinary bladder.

Authors:  Carla L Ellis; Alex G Chang; Ashley Cimino-Mathews; Pedram Argani; Ramy F Youssef; Payal Kapur; Elizabeth A Montgomery; Jonathan I Epstein
Journal:  Am J Surg Pathol       Date:  2013-11       Impact factor: 6.394

7.  GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors.

Authors:  Markku Miettinen; Peter A McCue; Maarit Sarlomo-Rikala; Janusz Rys; Piotr Czapiewski; Krzysztof Wazny; Renata Langfort; Piotr Waloszczyk; Wojciech Biernat; Jerzy Lasota; Zengfeng Wang
Journal:  Am J Surg Pathol       Date:  2014-01       Impact factor: 6.394

Review 8.  Breast metastasis of gastric signet-ring cell carcinoma: a case report and literature review.

Authors:  Chun-Lan He; Ping Chen; Bing-Lan Xia; Qin Xiao; Feng-Lin Cai
Journal:  World J Surg Oncol       Date:  2015-03-26       Impact factor: 2.754

9.  Poorer Prognosis of Primary Signet-Ring Cell Carcinoma of the Breast Compared with Mucinous Carcinoma.

Authors:  Xiufeng Wu; Zhenzhen Zhang; Xin Li; Qingzhong Lin; Gang Chen; Jianping Lu; Yi Zeng; Dan Hu; Kai Huang; Zhiwu Lin; Jun Yan
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.